Vertex Overview
Industry: Software Application
Sector: Technology
Vertex, Inc. provides tax technology solutions for retail, communication, leasing, retail trade, wholesale trade, technology, and manufacturing industries in the United States and internationally. It offers tax determination, compliance and reporting, tax data management, document management, analytics and insights, pre-built integration, and industry-specific solutions. The company sells its software products through software license and software as a service subscriptions. It also provides implementation and training services in connection with its software license and cloud subscriptions, transaction tax returns outsourcing, and other tax-related services. Vertex, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania. Vertex, Inc. operates as a subsidiary of Ebix, Inc. Vertex, Inc. provides tax technology solutions for retail, communication, leasing, retail trade, wholesale trade, technology, and manufacturing industries in the United States and internationally. It offers tax determination, compliance and reporting, tax data management, document management, analyt Read MoreMavefund brings filings, fundamentals, valuation, price history and news for Vertex into one research view. The sections below show what strengthens or weakens the research case.
Score
Reported Results
What the company reported, with filing details kept small.
Quarterly result summary
Revenue was $204M (+10.5% YoY); EPS was $0.2 (reported).
What changed
- Revenue +10.5% YoY to $204M; EPS reported to $0.2.
Guidance / outlook
we expect to result in expanding profitability and stronger cash generation in the third and fourth quarters.
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Other recent earnings materials
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
Vertex Pharma beats Q2 earnings and revenue estimates, raises guidance By Investing.com
Headline from Investing.com South Africa: Vertex Pharma beats Q2 earnings and revenue estimates, raises guidance By Investing.com.
Vertex Pharma beats Q2 earnings and revenue estimates, raises guidance
Headline from Investing.com: Vertex Pharma beats Q2 earnings and revenue estimates, raises guidance.
Vertex Pharmaceuticals (VRTX) Could Be 8% Undervalued Following Raised 2026 Guidance
Headline from Yahoo Finance: Vertex Pharmaceuticals (VRTX) Could Be 8% Undervalued Following Raised 2026 Guidance.
Vertex Pharmaceuticals (VRTX) Q1 2026 Earnings Call Transcript
Headline from Fortune: Vertex Pharmaceuticals (VRTX) Q1 2026 Earnings Call Transcript.
Vertex Pharmaceuticals (VRTX) Q1 2026 Earnings Call Transcript
Headline from Fortune: Vertex Pharmaceuticals (VRTX) Q1 2026 Earnings Call Transcript.
5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call
Headline from Yahoo Finance: 5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call.
Earnings Per Share
Return on Equity
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
Metric chart temporarily unavailable.
Net Margin
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Metric chart temporarily unavailable.
Leverage
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Metric chart temporarily unavailable.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.